Merlin, a neuro®bromatosis type-2 tumor suppressor, shows signi®cant sequence similarity to ERM (Ezrin/ Radixin/Moesin) proteins, general actin ®lament/plasma membrane cross-linkers, which are regulated in a Rhodependent manner. To understand its physiological functions, we compared merlin with ERM proteins in vivo and in vitro. Quantitative immunoblotting revealed that the molar ratio of merlin/ERM in cultured epithelial or non-epithelial cells was *0.14 or *0.05, respectively. After centrifugation of cell homogenate, merlin was mostly recovered in the insoluble fraction, whereas almost half of ERM proteins were found in the soluble fraction. Merlin and ERM proteins were concentrated at microvilli when introduced into ®broblasts. In contrast, in epithelial cells, introduced merlin was co-distributed with E-cadherin in lateral membranes, whereas ERM proteins were concentrated in apical microvilli. Finally, we examined the binding anity of merlin to Rho GDP dissociation inhibitor (Rho-GDI), to which N-terminal halves of ERM proteins but not the full-length molecules speci®cally bind. In vitro binding assays revealed that the N-terminal halves of merlin isoform-I and -II as well as full-length merlin isoform-II bound to Rho-GDI with similar binding anity to ERM proteins. Immunoprecipitation con®rmed these ®ndings in vivo. These ®ndings do not favor the notion that merlin functions simply in a redundant or competitive manner to ERM proteins.
Introduction
Merlin (or schwannomin) is a tumor suppressor protein for neuro®bromatosis type-2, an autosomal dominant disease, which is characterized by the development of bilateral vestibular Schwann cell tumors (schwannomas), meningiomas, spinal shwannomas, and/or subcapsular lens opacities (Martuza and Eldridge, 1988; Evans et al., 1992) . Antisense suppression of merlin expression results in inhibition of cell adhesion as well as an increase in proliferation in culture (Huynh and Pulst, 1996) . Knockout of the merlin gene in mice resulted in lethal defects in the initiation of gastrulation during embryogenesis and heterozygous mutation in mice induced a range of highly metastatic tumors (McClatchey et al., 1997 (McClatchey et al., , 1998 .
Merlin is homologous to ERM (Ezrin/Radixin/ Moesin) family proteins: *49% identity overall and especially *65% identity in their N-terminal halves (Sato et al., 1992; Rouleau et al., 1993; Trofatter et al., 1993) . ERM proteins are thought to function as general cross-linkers between plasma membranes and actin ®laments (for reviews, Arpin et al., 1994; Tsukita et al., 1997a,b; Bretscher et al., 1997; Vaheri et al., 1997) . The N-terminal halves of ERM proteins bind directly to adhesion molecules such as CD44, ICAM-1/ 2/3, and CD43 Helander et al., 1996; Hirao et al., 1996; Serrador et al., 1997 Serrador et al., , 1998 Yonemura et al., 1998) , and indirectly to Na + -H + exchanger type 3 (NHE3), the b 2 adrenergic receptor and the cystic ®bromatosis transmembrane conductance regulator (CFTR) through the NHE-regulatory factor (NHE-RF)-family proteins (Rezek et al., 1997; Hall et al., 1998a,b; Short et al., 1998; Yun et al., 1998) . The C-terminal region is the major actin-binding domain (Turunen et al., 1994; Pestonjamasp et al., 1995) , and an additional two actin-binding domains have recently been identi®ed in the middle and Nterminal regions Roy et al., 1997) . ERM proteins are thought to take inactive and active forms in terms of their cross-linking activity. In the inactive closed forms which exist in soluble form in the cytoplasm, the N-and C-terminal halves are intramolecularly associated with each other to mutually suppress the membrane-and actin-binding activities (Berryman et al., 1995; Gary and Bretscher, 1995; Magendantz et al., 1995; Martin et al., 1995) . Some signals may open these closed forms of ERM proteins to activate their cross-linking activity. ERM proteins were reported to be phosphorylated on tyrosine-as well as serine/threonine-residues in vivo (Gould et al., 1986; Hanzel et al., 1991; Egerton et al., 1992; Thuillier et al., 1994; Chen et al., 1995; Nakamura et al., 1995; Crepaldi et al., 1997) as well as to bind to PIP 2 (Niggli et al., 1995; Hirao et al., 1996) . Furthermore, a close relationship between ERM proteins and Rho-dependent signaling has been identi®ed; the C-terminal ends of ERM proteins are phosphorylated in the downstream of Rho (Matsui et al., 1998) , and the Nterminal halves of ERM proteins bind directly to Rho-GDI, Rho GDP dissociation inhibitor (Hirao et al., 1996; Takahashi et al., 1997) .
Some of these characteristics of ERM proteins have been reported to be shared by merlin. When merlin was introduced into cultured ®broblasts, it was colocalized with CD44 at microvilli . Furthermore, the N-terminal half of merlin bound to the cytoplasmic domain of CD44 and to NHE-RF (Murthy et al., 1998) in vitro, suggesting an interaction between its N-terminal half and plasma membranes. Merlin has two major alternatively spliced isoforms, I and II, which dier at their C-terminal ends (Hara et al., 1994) . Although neither of these C-terminal ends shows any similarity to those of ERM proteins with their major actinbinding domain, merlin was reported to bind to actin ®laments in its middle region (Xu and Gutmann, 1998) . Interdomain interaction between N-and C-terminal halves has been suggested in isoform-I without aecting its binding anity to actin ®laments or to NHE-RF (Murthy et al., 1998; Xu and Gutmann, 1998) . No such interdomain interaction has been detected in isoform-II (Sherman et al., 1997) .
Similarity between merlin and ERM proteins led us to speculate that merlin is somehow functionally redundant with ERM proteins, or alternatively that merlin may function as a competitive inhibitor of ERM proteins. However, our knowledge on merlin, especially regarding similarities and dierences between merlin and ERM proteins, is still limited. In this study, we compared the levels of expression and subcellular distributions of merlin and ERM proteins in cultured epithelial and non-epithelial cells as well as their interactions with Rho-GDI.
Results

Expression levels of merlin and ERM proteins in cultured cells
We estimated the expression levels of merlin and ERM proteins in cultured epithelial MTD-1A cells as well as HeLa and Swiss 3T3 cells. This was performed by comparing the staining intensities of merlin or ERM proteins bands from cell lysate on immunoblots ( Figure  1A ) with those of various amounts of authentic puri®ed recombinant merlin or ERM proteins, respectively. As shown in Figure 1A , the expression level of merlin in MTD-1A cells was signi®cantly higher than those in HeLa and Swiss 3T3 cells, and merlin was detected as several bands with distinct electrophoretic mobilities probably due to dierent levels of phosphorylation (Shaw et al., 1998b) . Quantitative estimation revealed that merlin accounted for 0.1%, 0.02% and 0.02% of the total cell lysate from MTD-1A, HeLa, and Swiss 3T3 cells, respectively, and that total ERM proteins accounted for 0.7%, 0.4% and 0.3% of those respective cell lines ( Figure 1B ). Since merlin, ezrin, radixin and moesin show similar molecular masses, the molar ratios of merlin/ERM proteins were calculated as 0.14, 0.06 and 0.05 in respective cell lines ( Figure 1C ). The level of merlin expression in MDCK cells, another epithelial cell line, was compatible with that in MTD-1A cells (data not shown).
Partition of merlin in insoluble membrane/cytoskeleton fraction
To biochemically assess the subcellular localization of merlin, after MTD-1A, Swiss 3T3, and Hela cells were homogenized in physiological saline solution in the presence of the phosphatase inhibitor, each total homogenate was divided into the soluble and insoluble fractions by centrifugation (Figure 2 ). Immunoblotting showed that merlin was mostly recovered in the insoluble membrane/cytoskeleton fraction, whereas ERM proteins were almost equally partitioned into the soluble and insoluble fractions, in all cell lines examined. Interestingly, when cells were homogenized in the absence of the phosphatase inhibitor, 20 ± 50% of merlin was recovered in the soluble fraction ( Figure  2 ), suggesting that merlin was translocated from the insoluble to soluble fraction by dephosphorylation.
Subcellular localization of transfected merlin
Next, we examined the subcellular distribution of transfected merlin by immuno¯uorescence microscopy in HeLa, Swiss 3T3, MTD-1A and MDCK cells. No dierences were detected between isoforms-I and -II or between C-terminally HA-tagged and C-terminally GFP-tagged merlin in any of these cell lines (Shaw et al., 1998c) . Thus, the results obtained with the HAtagged isoform-I will be shown here. When HA-merlin was transiently expressed in HeLa and Swiss 3T3 cells, Figure 3A ) (den Bakker et al., 1995; GonzalezAgosti et al., 1996; Scherer and Gutmann, 1996; Deguen et al., 1998; Shaw et al., 1998c; . When the expression level was relatively low, HA-merlin was colocalized with endogenous ERM proteins. However, in cells expressing large amounts of HA-merlin, endogenous ERM proteins appeared to be driven out from microvilli ( Figure 3A and B).
In marked contrast, when HA-merlin was transiently expressed in cultured epithelial MTD-1A or MDCK cells, it was mostly targeted to lateral membranes ( Figure 3C ), showing distinct subcellular localization from endogenous ERM proteins, most of which were concentrated at microvilli and cell-cell borders on apical membranes ( Figure 3D ). When MTD-1A cells were doubly stained with anti-HA mAb and anti-Ecadherin pAb, confocal immuno¯uorescence microscopy revealed that HA-merlin was colocalized with E-cadherin at lateral membranes (Figure 4 ). Endogenous merlin in these epithelial cells was very dicult to visualize clearly by immuno¯uorescence microscopy probably due to its low expression level, but one of our mAbs (N3-11) raised against recombinant N-merlin weakly but signi®cantly stained the cell-cell borders and lateral membranes of cultured MTD-1A cells ( Figure 3E and F).
In vitro binding assay between merlin and Rho-GDI
The N-terminal halves of ERM proteins but not the full-length molecules were recently reported to directly bind to Rho-GDI (Takahashi et al., 1997) . Thus, we next examined whether merlin also binds to Rho-GDI. For the in vitro binding assay, we produced 35 S-labeled merlin and truncation mutants by translating their cDNAs in vitro in reticulocyte lysate; full-length isoform-I or -II (F-merlin-I or -II), or N-terminal half (N-merlin) that is shared by two isoforms, and Cterminal halves of isoform-I or -II (C-merlin-I or -II). These labeled merlin products were incubated with GST Rho-GDI fusion proteins and bound merlin products were eluted and examined by autoradiography.
35
S-labeled F-merlin-I appeared to split into double bands around 70 ± 75 kD ( Figure 5A ). To characterize these two bands, 35 S-labeled F-merlin-I was ®rst immunoprecipitated with two distinct anti-merlin pAbs, aN-merlin pAb and aC-merlin pAb, which Figure 2 Solubility of ERM proteins and merlin in MTD-1A and Swiss 3T3 cells. Cells were homogenized in physiological saline solution and separated into the soluble supernatant (S) and insoluble pellet (I) by centrifugation in the presence or absence of the phosphatase inhibitor. Equivalent amounts of supernatant and pellet were applied to SDS ± PAGE and then subjected to immunoblotting using anti-ERM pAb (TK89; A, C, E, G) and anti-merlin pAb (aN-merlin pAb; B, D, F, H). ERM proteins were almost equally partitioned into soluble and insoluble fractions irrespective of the phosphatase inhibitor. Merlin was mostly recovered in the insoluble fraction in the presence of the phosphatase inhibitor, whereas in the absence of the phosphatase inhibitor 20 ± 50% of merlin was recovered in the soluble fraction Slabeled F-merlin-I (F-merlin-I), F-merlin-II (F-merlin-II), N-merlin (N-merlin) or C-merlin-I (C-merlin-I) with GST Rho-GDI (GST Rho-GDI)-or GST (GST)-bound glutathione beads. There was no background binding to GST beads (GST) . N-terminally deleted F-merlin-I (closed circle; see A), but not intact F-merlin-I (closed triangle; see A), bound to Rho-GDI. In contrast, both upper and lower bands of F-merlin-II bound to Rho-GDI. N-merlin, but not C-merlin-I, showed anity to Rho-GDI. (C) Glutathione-eluates from the mixture of in vitro translated 35 S-labeled full-length radixin (F-radixin) or N-terminal half of radixin (N-radixin) with GST Rho-GDI (GST Rho-GDI)-or GST (GST)-bound glutathione beads. N-radixin, but not F-radixin, bound to Rho-GDI. Molecular masses standards (kD) are shown at the left recognized the N-terminal end and C-terminal half of F-merlin-I, respectively. As shown in Figure 5A , aNmerlin pAb speci®cally immunoprecipitated the upper band, while aC-merlin pAb pulled down both upper and lower bands. Furthermore, the upper 35 S-labeled Fmerlin-I band showed the same electrophoretic mobility as the endogenous merlin immunoprecipitated from the cell lysate of metabolically labeled MTD-1A cells (data not shown). These observations indicated that the upper band corresponded to fully translated F-merlin-I, and that the lower band might represent a deleted merlin-I lacking the N-terminal end.
S-labeled F-merlin-II also showed similar double bands which were derived from full-length and Nterminally deleted merlin-II Figure 5B ).
When the eluate from GST Rho-GDI/ 35 S-labeled Fmerlin-I was examined, autoradiography revealed that N-terminally deleted F-merlin-I (lower band), but not intact F-merlin-I (upper band), bound to Rho-GDI ( Figure 5B ). In contrast, both upper and lower bands of F-merlin-II bound to Rho-GDI. Furthermore, as shown in Figure 5B , N-merlin clearly bound to Rho-GDI, whereas C-merlin-I showed no anity to Rho-GDI. Thus, we concluded that Rho-GDI bound to the N-terminal half of merlin, and that this Rho-GDI binding domain was exposed in F-merlin-II but not in F-merlin-I.
Next, direct N-merlin/Rho-GDI binding and its anity were examined using GST Rho-GDI and puri®ed N-merlin produced in E. Coli ( Figure 6A ). GST Rho-GDI-bound glutathione-beads were mixed with puri®ed N-merlin in the physiological saline solution, and Rho-GDI-bound N-merlin was eluted from beads with a solution containing glutathione. The amount of eluted N-merlin was evaluated by immunoblotting with aN-merlin pAb. As shown in Figure 6B , signi®cant amounts of N-merlin bound to Rho-GDI directly at physiological ionic strength. Then, using this system, the anity between Rho-GDI and N-merlin was quantitatively estimated by determining the relationship of the amounts of Rho-GDI-bound N-merlin with the amounts of free Nmerlin. These analyses were performed under conditions in which no binding was detected between Nmerlin and GST beads. As shown in Figure 6C , Nmerlin/Rho-GDI binding was saturable, and Scatchard analysis indicated the dissociation constant to be *0.2 mM. This value was similar to the N-radixin/ Rho-GDI dissociation constant of *0.6 mM reported previously (Takahashi et al., 1997) . Furthermore, when 0.01 ± 1 mM of N-merlin was incubated with GST Rho-GDI-bound glutathione beads in the presence of 0.05 mM of N-radixin, N-merlin competed with N-radixin for the binding to Rho-GDI ( Figure  7) . Figure 6 Estimation of the dissociation constant between Nmerlin and Rho-GDI. (A) Coomassie brilliant blue staining of puri®ed recombinant proteins used in the in vitro binding assay (GST, GST Rho-GDI, and N-merlin). GST fusion protein with Rho-GDI (GST Rho-GDI) and GST (GST) were produced in E.coli and absorbed onto the glutathione-beads. GST N-merlin was also produced in E.coli and absorbed onto the glutathionebeads, then N-merlin (N-merlin) was released from the beads by thrombin cleavage. (B) Glutathione-eluates from the mixture of puri®ed N-merlin with GST Rho-GDI (GST Rho-GDI)-or GST (GST)-bound glutathione beads. Bound N-merlin (N-merlin) was detected by immunoblotting with anti-N-merlin pAb (aN-merlin pAb). (C) Quantitative analysis of the binding between N-merlin and GST Rho-GDI. Various concentrations (0.03 ± 2.4 mM) of recombinant N-merlin were added to the GST-or GST Rho-GDI-bound beads, and 15% of each glutathione eluate was applied to each lane of SDS ± PAGE followed by immunoblotting with aN-merlin pAb (upper panel). No binding of N-merlin to GST beads was detected, and the bound N-merlin was estimated by the intensity of N-merlin bands in glutathione eluates (upper panel) by comparing the intensities of various amounts of authentic puri®ed N-merlin resolved and immunoblotted on the same gels (data not shown). The amount of bound versus free Nmerlin is plotted in the lower panel. Scatchard analysis (inset) indicated that the K d was *0.2 mM Figure 7 Competitive binding of N-merlin and N-radixin to Rho-GDI. 0.01, 0.1, 1 mM N-merlin was incubated with GST Rho-GDI-bound glutathione beads in the presence of 0.05 mM Nradixin. 15% of each glutathione eluate was immunoblotted with aN-merlin pAb and anti-ERM pAb (TK88). N-merlin bound to Rho-GDI with a competitive manner with N-radixin
Co-immunoprecipitation of merlin with Rho-GDI
We then attempted to con®rm the merlin/Rho-GDI interaction in vivo by immunoprecipitation from cultured cells using anti-Rho-GDI mAb. Various combinations of cell types, detergent conditions and antibodies were tested, and ®nally we found that a combination of MTD-1A cells (or MDCK cells), RIPA buer and anti-Rho-GDI mAbs (JK5 or JK21) was most appropriate. When MTD-1A cell lysate was immunoprecipitated with anti-Rho-GDI antibody, immunoblotting with aN-merlin pAb revealed that endogenous merlin was reproducibly co-immunoprecipitated with endogenous Rho-GDI ( Figure 8A ). As shown in Figure 8B , RT ± PCR revealed that isoform-II of merlin was mainly expressed in MTD-1A cell with no detectable isoform-I. Therefore, we concluded that isoform-II of merlin was co-immunoprecipitated with Rho-GDI in this experiment. In formaldehyde or methanol ®xed cells, it was very dicult to show this merlin/Rho-GDI interaction, i.e. their colocalization, at the immuno¯uorescence microscopical level. However, when HA-merlin transfected MTD-1A cells were treated with a cross-linker DSP followed by immunouorescence microscopy, some fraction of Rho-GDI appeared to be colocalized with merlin at lateral membranes ( Figure 8C ).
Discussion
Since the amino-terminal half of merlin shows marked sequence similarity to those of ERM proteins, it has been speculated that merlin may function physiologically in a competitive or redundant manner to ERM proteins (Sato et al., 1992b; Rouleau et al., 1993; Trofatter et al., 1993) . To evaluate this speculation, the molar ratio of merlin and ERM proteins in normal cells should be clari®ed, but there have been no previous studies of this ratio. In this study, quantitative comparison revealed that the molar ratios of merlin/ERM were *0.15 and *0.05 in MTD-1A and HeLa/Swiss 3T3 cells, respectively. When merlin was overexpressed in non-epithelial cells, it competed out endogenous ERM proteins from microvilli as shown in the present as well as in the previous studies . However, the endogenous merlin/ERM molar ratio of 0.05 ± 0.15 suggests that such competition with ERM proteins is not the physiological function of merlin in normal cells.
The next question is then whether merlin is functionally redundant to ERM proteins. When the expression of all ERM proteins was suppressed by antisense oligonucleotides in MTD-1A cells, cell-cell/ cell-matrix adhesion and microvilli formation were severely aected (Takeuchi et al., 1994) . Antisense suppression of merlin expression results in inhibition of cell adhesion and an increase in proliferation in culture (Huynh and Pulst, 1996) . Merlin-de®cient mice showed an embryonic lethal phenotype (McClatchey et al., 1997) , and moesin-de®cient mice showed no phenotypic abnormalities (Doi et al., 1999) . Furthermore, distinct subcellular localizations were previously observed for merlin and ERM proteins; in some glioma cells, endogenous merlin was concentrated at rue membranes, showing distinct localization from ERM proteins (Gonzalez-Agosti et al., 1996; Shaw et al., 1998c; and in Drosophila moesin was concentrated at cell-cell junctions and microvilli, while merlin was found in punctate structures at the Figure 8 Co-immunoprecipitation of endogenous merlin with Rho-GDI. (A) MTD-1A cells were lysed with RIPA buer and immunoblotted with anti-N-merlin pAb (aN-merlin pAb) (lysate). The lysate was then immunoprecipitated with normal mouse (IgG (mouse IgG) or anti-Rho-GDI mAb (JK5; aRho-GDI). Merlin bands (merlin) were detected only in Rho-GDI immunoprecipitates by immunoblotting with anti-N-merlin pAb (aN-merlin pAb). (B) RT ± PCR was performed from MTD-1A cells using primers which were designed to give 100 bp-and 150 bp-bands for merlin isoforms-I and II, respectively. Merlin-II was mainly expressed in MTD-1A cells with no detectable merlin-I. (C) When DSP-cross-linked HA-merlin-transfected MTD-1A cells were processed for immuno¯uorescence microscopy, colocalization of Rho-GDI with HA-merlin was detected at lateral membranes membrane and in the cytoplasm (McCartney and Fehon, 1996; LaJeunesse et al., 1998) . In this study we found biochemically that merlin was mostly concentrated in the insoluble fraction, and that ERM proteins were almost equally partitioned into the soluble and insoluble fractions. Furthermore, in epithelial cells merlin was concentrated at lateral membranes together with E-cadherin, whereas ERM proteins were concentrated at microvilli and cell-cell borders on apical membranes, suggesting some unique roles of merlin in cell-cell adhesion. These ®ndings do not support the notion that merlin functions in a redundant manner to ERM proteins in normal cells.
These observations, therefore, raise the question of what is the physiological signi®cance of the sequence similarity between the N-terminal halves of merlin and ERM proteins. One interesting feature of the Nterminal halves of ERM proteins is the binding anity to Rho-GDI, a GDP dissociation inhibitor of Rho-family members (Hirao et al., 1996; Takahashi et al., 1997) . On in vitro and in vivo analyses, the Nterminal halves of ERM proteins were shown to directly bind to Rho-GDI and suppress Rho-GDI activity, i.e. release GDP-Rho from Rho-GDI followed by their activation (Takahashi et al., 1997) . In this study, we showed that the N-terminal half of merlin also directly bound to Rho-GDI with similar anity. Preliminary experiments did not detect the inhibition of Rho-GDI activity by N-merlin, but to clarify this point more detailed analyses are required. As the actin ®lament/plasma membrane cross-linking activity of ERM proteins is regulated by the Rho familydependent signaling pathway (Hirao et al., 1996; Mackay et al., 1997; Matsui et al., 1998; Shaw et al., 1998a) , these ®ndings led us to speculate that some function of merlin is also regulated by Rho familyrelated signaling and that the similar sequences found in N-terminal halves of both merlin and ERM proteins are somehow involved in Rho family-dependent regulation through direct binding to Rho-GDI. It should be noted that the tumor suppressor gene for neuro®bromatosis type-1 encodes a protein named neuro®bromin which shows GAP activity for Ras and related small GTP-binding proteins (Xu et al., 1990) . It is thus tempting to speculate that both type-1 and -2 neuro®bromatosis are caused by the disturbance of small GTP-binding protein-dependent signaling pathways, Ras-related and Rho-related G-proteins, respectively.
Finally, we should discuss the alternatively spliced variants of merlin, merlin-I and -II, which share the same N-terminal half domain (Hara et al., 1994) . Both variants were reported to be expressed in various types of cells in various ratios, and showed similar subcellular distribution (Shaw et al., 1998c) . As mentioned in the Introduction, ERM proteins adopt a closed form through the intramolecular association between their N-and C-terminal halves, and these closed forms are inactive in binding to actin ®laments or integral membrane proteins such as CD44 (Berryman et al., 1995; Gary and Bretscher, 1995; Magendantz et al., 1995; Martin et al., 1995) . In contrast, full-length merlin-I and -II were reported to directly associate with actin ®laments as well as CD44 Xu and Gutmann, 1998) , although similarly to ERM proteins the N-terminal half of merlin-I can directly associate with its C-terminal half (Sherman et al., 1997; Huang et al., 1998) . In this study, we found that full-length merlin-II but not fulllength merlin-I bound to Rho-GDI at least in vitro. Interestingly, N-terminally truncated merlin-I bound to Rho-GDI. As full-length ERM proteins cannot bind to Rho-GDI, there must be some dierences in the mechanism of regulation of the molecular conformation between merlin-I and -II and ERM proteins.
This study revealed dierences between merlin and ERM proteins. Further detailed comparisons between these molecules will lead to a better understanding of the molecular bases for tumor progression caused by merlin defects in neuro®bromatosis type-2.
Materials and methods
Antibodies and cultured cells
Anti-merlin polyclonal antibody (sc331) was purchased from Santa Cruz Biochemistry (Santa Cruz, CA, USA). Since sc331 was generated against 2-21 amino-acids of human merlin, we called it`aN-merlin pAb'. Another anti-merlin pAb (C80) was raised in rabbits against amino acids 409 ± 420 of mouse merlin, which was then called`aC-merlin pAb'. Anti-merlin mAb (N3-11) which recognized endogenous merlin was raised in rats against recombinant GST N-merlin fusion protein puri®ed from E. Coli. To detect all ERM proteins on immuno¯uorescence microscopy or on immunoblotting, anti-ERM mAb (CR22) (Sato et al., 1991) or anti-ERM pAb (TK88 and TK89) (Kondo et al., 1997) were used, respectively. TK88 recognized the N-terminal halves of ERM proteins and TK89 recognized the C-terminal halves of ERM proteins. Rabbit anti-mouse E-cadherin pAb was provided by Dr M Takeichi (Kyoto University, Kyoto, Japan). Mouse anti-HA mAb (12CA5) was purchased from Boehringer Mannheim Biotechnology (Mannheim, Germany), and rabbit anti-HA pAb was purchased from Santa Cruz Biochemistry (Santa Cruz, CA, USA). Mouse anti-Rho-GDI mAbs (JK5 and JK21) were provided by Drs T Sasaki and Y Takai (Osaka University, Osaka, Japan). Mouse MTD-1A cells, mouse Swiss 3T3 cells, canine MDCK cells, and human HeLa cells were cultured in DME supplemented with 10% FCS.
Determination of expression levels of merlin and ERM proteins
MTD-1A cells, Swiss 3T3 cells and HeLa cells were cultured in subcon¯uent monolayers in 10 cm dishes. After three washes with PBS, cells were harvested with a rubber policeman in sample buer. Cell lysates (6 mg of total proteins per each cell line) were applied to SDS ± PAGE, followed by immunoblotting with aN-merlin pAb. The amount of merlin in each cell line was quanti®ed by comparing the intensity of the merlin band on immunoblots with that of authentic puri®ed GST N-merlin fusion protein on the same gel. Similarly, cell lysates (1.5 mg of total proteins per each cell line) were applied to SDS ± PAGE and immunoblotted with anti-ERM pAb (TK89) and the amounts of ERM proteins in each cell line were estimated by comparing the intensity of ERM protein bands on immunoblots with that of authentic puri®ed GST C-radixin fusion protein.
Preparation of soluble and insoluble fractions
Subcon¯uent MTD-1A cells, Swiss 3T3 cells or HeLa cells were washed three times with PBS and harvested with a rubber policeman in buer S (130 mM KCl, 20 mM NaCl, 2 mM EDTA, 1 mM EGTA, 10 mM HEPES, 1 mM pamidinoPMSF and 4 mg/ml leupeptin, pH 7.4) with or without 20 nM calyculin A (Research Biochemicals International, Natick, MA, USA). Cell homogenates were prepared by three strokes in a Kontes homogenizers (Kontes, Vineland, NJ, USA), and centrifuged at 100 000 g for 15 min at 48C to recover the soluble and insoluble fractions in the supernatant and pellet, respectively. Equivalent amounts of supernatant and pellet were applied to SDS ± PAGE, and subsequently subjected to immunoblotting with aN-merlin pAb or anti-ERM pAb (TK89).
Construction and transfection of merlin cDNA A 1.8 kb cDNA fragment with EcoRI and BamHI sites at both ends, encoding the full-length mouse merlin isoform-I (F-merlin-I (Hara et al., 1994) , was obtained from a mouse lung cDNA library by polymerase chain reaction (PCR), and subcloned into pBluescript SK 7 (Stratagene, La Jolla, CA, USA). To obtain cDNA for mouse full-length merlin isoform-II (F-merlin-II), a cDNA fragment encoding the Cterminal region including alternatively spliced exon 16 (Hara et al., 1994) was generated by PCR, and was substituted for the corresponding C-terminal region of F-merlin-I cDNA. The entire coding sequences of F-merlin-I and -II were engineered to have an in¯uenza hemagglutinin (HA) epitope tag at their 3' ends. These 3'-HA-tagged constructs of Fmerlin-I and -II were then cloned into the CAG promoterdriven mammalian expression vector (pCAG). These expression vectors were then transfected into MTD-1A, MDCK, HeLa and Swiss 3T3 cells using LipofectAMINE (GIBCO ± BRL, Gaithersburg, MD, USA).
In vitro translation of merlin cDNA and radixin cDNA F-merlin-I (1 ± 596 a.a.) and -II (1 ± 591 a.a.) cDNAs and Fradixin cDNAs (1 ± 583 a.a.) were subcloned into pGEM-T easy (Promega, Madison, WI, USA) downstream from the T7 RNA polymerase promoter. cDNA fragments encoding the N-terminal half of merlin (N-merlin) (1 ± 341 a.a.), C-terminal half of merlin-I (C-merlin-I) (345 ± 596 a.a.), C-terminal half of merlin-II (C-merlin-II) (345 ± 591 a.a.) and N-terminal half of radixin (1 ± 318 a.a.) were ampli®ed by PCR, then subcloned into pGEM-T easy downstream from the T7 RNA polymerase promoter. Sequences of these cDNAs were con®rmed. Coupled in vitro transcription/translation reactions were performed using the TnT protocol (Promega, Madison, WI, USA) according to the manufacturer's recommendations.
In vitro binding assay of in vitro translated merlin cDNA products with Rho-GDI Ten nmol of GST Rho-GDI or GST was immobilized onto 20 ml of glutathione-Sepharose 4B beads (Amersham Pharmacia Biotech, Bucks, UK). After washing three times with buer A (20 mM Tris-HCl, 100 mM KCl, 1 mM EDTA, 1 mM DTT, pH 7.5), beads were mixed with 40 ml of the in vitro translated products of merlin cDNAs or radixin cDNAs and gently mixed for 1 h at room temperature. The beads were washed ®ve times with buer A and the bound proteins were eluted from the beads by addition of 100 ml buer B (20 mM glutathione, 50 mM Tris-HCl, pH 8.0). Each eluate was separated by SDS ± PAGE and analysed by autoradiography.
Preparation of recombinant proteins
N-merlin cDNA (1 ± 341 a.a.) was cloned in frame into pGEX4T-1 vector (Amersham Pharmacia Biotech). pGEX-2T (Amersham Pharmacia Biotech) carrying the full-length bovine Rho-GDI cDNA was provided by Drs T Sasaki and Y Takai (Osaka University, Osaka, Japan). The GST fusion protein with the N-and C-terminal halves of radixin was described previously (Matsui et al., 1998) . Expression and puri®cation of GST fusion proteins were performed essentially according to the method described in the manufacturer's instructions. Brie¯y, logarithmically growing cultures of E. coli (DH5a) transformed with pGEX recombinants were incubated with 0.2 mM isopropyl b-Dthiogalactopyranoside for 5 h at 308C. Cells were then pelleted, resuspended in buer C (20 mM Tris-HCl, 1 mM EDTA, 1 mM DTT, 1 mM p-amidinoPMSF, 4 mg/ml leupeptin, pH 7.5) and sonicated on ice. After centrifugation (100 000 g, 1 h at 48C), the supernatant was mixed with glutathione-Sepharose 4B beads (Pharmacia Diagnostics AB) equilibrated with buer C, and then gently shaken for 30 min at 48C. After washing with buer A, the GST fusion proteins were eluted with buer D (10 mM glutathione, 50 mM TrisHCl, pH 8.0), and then dialyzed against buer E (20 mM Tris-HCl, 1 mM EDTA, 1 mM DTT, pH 7.5). Then the GST fusion proteins were re-absorbed to glutathione-Sepharose 4B beads and used for binding assay. Recombinant N-merlin and N-radixin were puri®ed by cleaving o the GST carrier which was bound to beads by digestion with thrombin.
Estimation of the dissociation constant between N-merlin and Rho-GDI
To estimate the dissociation constant between N-merlin and Rho-GDI, 20 ml of glutathione-Sepharose 4B beads slurry containing 10 nmol of GST Rho-GDI or GST was incubated in 100 ml of buer A containing 0.03 ± 2.4 mM N-merlin for 30 min at 48C. The beads were washed ®ve times with buer A and bound N-merlin was eluted with 100 ml of buer B. The amount of N-merlin in each eluate was quanti®ed by comparing the intensities of immunoblotted N-merlin bands in eluates with those of various amounts of authentic puri®ed N-merlin resolved and immunoblotted in the same gel. The intensity of the immunoblotted band was measured by densitometry using Adobe Photoshop TM 3.0J histogram (San Jose, CA, USA), and a Scatchard plot of the data was generated. Experiments were repeated three times for each estimation of the dissociation constant.
Immunoprecipitation
Subcon¯uent monolayer cultures of MTD-1A cells on 10 cm dishes were used for immunoprecipitation. After washing twice with PBS, cells were lysed and incubated on ice for 15 min in 1 ml of RIPA buer (0.1% SDS, 0.5% deoxycholate, 1% Nonidet P-40, 150 mM NaCl, 50 mM Tris-HCl, 1 mM p-amidinoPMSF and 4 mg/ml leupeptin, pH 7.5). The RIPA lysate was removed from the dish after fully dislodging any remaining cellular debris with a rubber policeman. The RIPA lysate was incubated for an additional 10 min, and then clari®ed by centrifugation at 12 000 g for 15 min. The RIPA-soluble supernatant was immunoprecipitated with 20 ml of protein G-Sepharose 4B (Zymed Labs, Inc., South San Francisco, CA, USA) conjugated with antiRho-GDI mAb (JK5 or JK21) or with control mouse IgG. Sepharose 4B-bound immune complexes were washed ®ve times with RIPA buer. Immune complexes were then eluted by boiling in sample buer and resolved by SDS ± PAGE, followed by immunoblotting with aN-merlin pAb.
RT ± PCR to determine expression of isoform -I and/or -II in MTD-1A cells
Poly (A)
+ RNA was prepared from the total RNA by using oligo(dT)-cellulose (New England Bolas). First strand cDNA was prepared from the poly (A) + RNA with Superscript II reverse transcriptase (GIBCO/BRL) using the oligo(dT) primer. The cDNA template was then subjected to PCR using primers 3AS1 (5'-TCTTCAAAGAAGGCCACTCG-3') and 5AS1
(5'-ACACAGCGAGAGCTCAGACAGA-3') (Hara et al., 1994) . Since 3AS1 was annealed to the 3'-end of the open reading frame of merlin -I and -II and 5AS1 annealed to the portion around 1700 bp from the initial codon of merlin-I and -II, these primers¯ank the insertion site around nucleotide 1740 to give the PCR products of *100 bp and *150 bp for merlin-I and -II, respectively.
Gel electrophoresis and immunoblotting
After one-dimensional SDS ± PAGE (12.5 ± 15%) was performed, proteins were electrophoretically transferred from gels on nitrocellulose membranes, which were then incubated with the ®rst antibody (aN-merlin pAb, TK88 or TK89). Bound antibodies were visualized using biotinylated secondary antibody followed by avidin-conjugated alkaline phosphatase and the appropriate substrates as described by the manufacturer (Amersham Pharmacia Biotech).
Immuno¯uorescence microscopy
Indirect immuno¯uorescence microscopy was performed as described previously . All procedures were performed at room temperature. Cultured cells on coverslips were ®xed in 3% formalin for 10 min and treated with 0.1% Triton X-100 in PBS for 10 min. The second antibody used was the Cy2-or Cy3-conjugated antibody which reacted with rabbit, mouse or rat IgG (Amersham Pharmacia Biotech). The samples were washed with PBS three times, embedded in 95% glycerol-PBS containing 0.1% para-phenylendiamine and 1% n-propylgalate.
For immuno¯uorescence microscopy of Rho-GDI in MTD-1A cells, the cells were incubated in PBS with 200 mg/ml of the cross-linker dithiobis-succinimidyl-propionate(DSP) (Pierce, Rockford, IL, USA) at room temperature for 20 min. After being washed in PBS, DSP was quenched by 50 mM glycine in PBS at room temperature for 5 min then processed for conventional immuno¯uorescence microscopy as described above. Samples were examined using ā uorescence microscope (Axiophoto photomicroscope; Carl Zeiss, Inc., Thornwood, NY, USA), or an MRC 1024 confocal¯uorescence microscope (Bio-Rad Laboratories, Hercules, CA, USA) equipped with a Zeiss Axiophoto photomicroscope.
